AAX Biotech attends Antibody Engineering & Therapeutics US
AAX Biotech is excited to attend the Antibody Engineering & Therapeutics US conference in San Diego, US (Dec. 15-18), represented by Mats AA Persson, Co-Founder and Advisor.
This conference sets the stage for breakthrough discussions in next-generation antibody therapeutics. Please reach out to us to discuss our cutting-edge technologies Seqitope, for high-throughput and high-resolution epitope mapping, and Opti-mAb, a novel scFv format.
